A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Clinical trial NCT02181413 · COMPLETED

Trial details

NCT number: NCT02181413
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma Autologous Stem Cell Transplant

Start date: 2014-07-16
Primary completion: 2018-04-16
Enrollment: 656

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.